Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Amneal Pharmaceuticals Inc (AMRX)

Amneal Pharmaceuticals Inc (AMRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,894,958
  • Shares Outstanding, K 314,363
  • Annual Sales, $ 3,019 M
  • Annual Income, $ 72,060 K
  • EBIT $ 392 M
  • EBITDA $ 638 M
  • 60-Month Beta 1.35
  • Price/Sales 1.29
  • Price/Cash Flow 7.96
  • Price/Book N/A

Options Overview Details

View History
  • Implied Volatility 130.35% (-29.79%)
  • Historical Volatility 32.81%
  • IV Percentile 92%
  • IV Rank 74.60%
  • IV High 173.90% on 12/08/25
  • IV Low 2.47% on 09/09/25
  • Expected Move (DTE 28) 1.84 (14.95%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 45
  • Volume Avg (30-Day) 111
  • Put/Call OI Ratio 0.25
  • Today's Open Interest 9,181
  • Open Int (30-Day) 9,220
  • Expected Range 10.50 to 14.18

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate 0.15
  • Number of Estimates 1
  • High Estimate 0.15
  • Low Estimate 0.15
  • Prior Year 0.19
  • Growth Rate Est. (year over year) -21.05%

Price Performance

See More
Period Period Low Period High Performance
1-Month
11.75 +5.02%
on 03/13/26
14.84 -16.85%
on 02/25/26
-2.26 (-15.48%)
since 02/19/26
3-Month
11.75 +5.02%
on 03/13/26
15.42 -19.97%
on 02/17/26
-0.23 (-1.83%)
since 12/19/25
52-Week
6.68 +84.73%
on 04/10/25
15.42 -19.97%
on 02/17/26
+3.61 (+41.35%)
since 03/19/25

Most Recent Stories

More News
Q4 Earnings Roundup: Amneal (NASDAQ:AMRX) And The Rest Of The Generic Pharmaceuticals Segment

Q4 Earnings Roundup: Amneal (NASDAQ:AMRX) And The Rest Of The Generic Pharmaceuticals Segment

AMRX : 12.34 (-0.40%)
3 Reasons to Avoid AMRX and 1 Stock to Buy Instead

3 Reasons to Avoid AMRX and 1 Stock to Buy Instead

AMRX : 12.34 (-0.40%)
3 Value Stocks We’re Skeptical Of

3 Value Stocks We’re Skeptical Of

FBIN : 40.90 (-1.09%)
RNG : 37.45 (+1.03%)
AMRX : 12.34 (-0.40%)
Amneal to Participate in Upcoming Investor Conference

BRIDGEWATER, N.J., March 05, 2026 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) today announced that Chirag Patel, Co-Chief Executive and President, will participate in a fireside chat...

AMRX : 12.34 (-0.40%)
Why Amneal (AMRX) Stock Is Trading Lower Today

Why Amneal (AMRX) Stock Is Trading Lower Today

AMRX : 12.34 (-0.40%)
Amneal (NASDAQ:AMRX) Beats Q4 CY2025 Sales Expectations

Amneal (NASDAQ:AMRX) Beats Q4 CY2025 Sales Expectations

AMRX : 12.34 (-0.40%)
Amneal: Q4 Earnings Snapshot

Amneal: Q4 Earnings Snapshot

AMRX : 12.34 (-0.40%)
Amneal Reports Fourth Quarter and Full Year 2025 Financial Results

‒ Full Year 2025 Performance Met or Exceeded All Guidance Metrics and 2026 Reflects Another Year of Growth – ‒ Q4 2025 Net Revenue of $814 million ; GAAP Net Income of $35 million...

AMRX : 12.34 (-0.40%)
Earnings To Watch: Amneal (AMRX) Reports Q4 Results Tomorrow

Earnings To Watch: Amneal (AMRX) Reports Q4 Results Tomorrow

AMRX : 12.34 (-0.40%)
Sparse Week for Macroeconomics

Monday Economic Lookahead Factory Orders (Dec.) Featured Earnings Dominion Energy (Q4) ...

NVDA : 178.56 (-1.02%)
TJX : 154.68 (+1.18%)
INTU : 455.24 (+1.89%)
MNST : 73.74 (-0.47%)
OKE : 88.39 (+2.55%)
AMRX : 12.34 (-0.40%)
FANG : 190.31 (+0.33%)
GTLS : 207.12 (+0.03%)
KDP : 27.15 (+0.30%)
BTSG : 43.99 (+2.14%)
HD : 328.21 (-0.82%)
EOG : 138.82 (+0.95%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Amneal Pharmaceuticals LLC is an integrated specialty pharmaceutical company. It focused on developing, manufacturing and distributing generic, brand and biosimilar products. The company operates primarily in North America, Asia and Europe. Amneal Pharmaceuticals LLC, formerly known as Impax Laboratories...

See More

Key Turning Points

3rd Resistance Point 12.93
2nd Resistance Point 12.71
1st Resistance Point 12.52
Last Price 12.34
1st Support Level 12.12
2nd Support Level 11.90
3rd Support Level 11.71

See More

52-Week High 15.42
Last Price 12.34
Fibonacci 61.8% 12.08
Fibonacci 50% 11.05
Fibonacci 38.2% 10.02
52-Week Low 6.68

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar